The Human Genome Is Having Its Facebook Moment
By Whet Moser,
Chicago Magazine
| 08. 09. 2016
Untitled Document
In June, 4.1 petabytes of cancer data went online on a new platform, run by the University of Chicago, called the Genomic Data Commons. Four petabytes is about sixteen times all the information in the Library of Congress—but only about four percent of the data stored by Facebook as of 2012.
In other words, the data we generate about how we live our lives is much more vast and organized than the data about biological life itself, and the technology used to organize it is more seamless and sophisticated. But given the evolution of technology, that makes sense. Consider how we documented day-to-day life before smartphones and services like Facebook: you had to have a camera, which wrote to a card, from which you transferred photos to a hard drive. That recorded limited metadata, generally date and time and some information about the camera itself.
As phones got better cameras and those cameras were connected by software to the phone’s other features, pictures could go straight to the cloud with location data; software on the other end could...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...